Osteoporosis Drug Stops Growth Of Breast Cancer Cells, Even In Resistant Tumors, Duke Cancer Institute Study
6/17/2013 7:11:38 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
A drug approved in Europe to treat osteoporosis has now been shown to stop the growth of breast cancer cells, even in cancers that have become resistant to current targeted therapies, according to a Duke Cancer Institute study. The findings, presented June 15, 2013, at the annual Endocrine Society meeting in San Francisco, indicate that the drug bazedoxifene packs a powerful one-two punch that not only prevents estrogen from fueling breast cancer cell growth, but also flags the estrogen receptor for destruction.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by